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Abstract 
Aims: The serotonin 2A receptor (HTR2A) is widely expressed in the brain and 
involved in the modulation of fear, mood, anxiety and other symptoms. HTR2A and HTR2A 
gene variations are implicated in depression, schizophrenia, anxiety and obsessive-compulsive 
disorder. To understand HTR2A signalling changes in psychiatric or neurodegenerative 
disorders, its normal pattern of brain expression and region specificity during development 
and aging needs to be clarified. The aim of the present study was to assess HTR2A expression 
through developmental and aging stages in six brain regions in postmortem human brain 
samples from individuals with no clinical or neuropathological evidence of neuropsychiatric 
disorders and to investigate the interaction with the rs6311 HTR2A promoter polymorphism. 
Methods: DNA, RNA and protein were isolated from postmortem brain samples including 
six regions (frontal cortex, striatum, amygdala, thalamus, brain stem and cerebellum) from 55 
individuals. HTR2A mRNA levels were assessed using quantitative real time RT-PCR, and 
HTR2A protein levels – with western blot. The rs6311 HTR2A polymorphism was analyzed 
with genotyping. Results: We found that HTR2A mRNA and protein levels are differentially 
regulated with age in different brain regions studied, but are not affected by gender. 
Significant changes in HTR2A expression with age were found in frontal cortex, amygdala, 
thalamus, brain stem, and cerebellum. Conclusions: Our results show plasticity and region 
specificity of HTR2A expression regulation in human brain with age, which may be important 
for the interaction with other neurotransmitter systems and for the occurrence of 
developmental periods with increased vulnerability to neuropsychiatric or neurodegenerative 
disorders. 
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Introduction 
The process of brain maturation extends from the fetal period, after birth and through 
adolescence, into young adulthood [1]. Neurodevelopmental factors have been implicated in 
the pathophysiology of many psychiatric disorders such as schizophrenia, autism, obsessive-
compulsive disorder (OCD) and attention deficit hyperactivity disorder [2]. Analyzing the 
normal pattern of expression of neurotransmitter receptors and other signalling molecules in 
the brain during development and aging may help better understand the pathological 
deviations in their expression occurring in psychiatric disorders.  
Serotonin (5-HT) is a neurotransmitter that regulates mood, anxiety, cognition, and 
developmental processes such as neurogenesis and axon branching [3]. The serotonin 2A 
receptor (HTR2A) is a serotonin receptor subtype, which plays an important role in the 
modulation of anxiety and mood [4, 5]. Furthermore, the HTR2A gene has been implicated by 
genetic studies in neuropsychiatric disorders as schizophrenia, depression, anxiety, OCD and 
eating disorders [6, 7]. One of the genetic polymorphisms of the HTR2A, associated with 
psychiatric disorders, including OCD, is the promoter -1438A/G polymorphism (rs6311) [8-
10]. HTR2A is expressed at the mRNA level in a number of different brain regions, and there 
is a great variability in the level of expression based on brain regions [11]. A recent study has 
determined the developmental regulation of HTR2A mRNA levels among other serotonin 
receptor subtypes in prefrontal cortex [12]. However, developmental regulation of expression 
may be different among diverse brain regions. Furthermore, it is important to determine also 
the developmental regulation of protein HTR2A expression, to account for the action of 
additional post-transcriptional regulatory mechanisms. 
The aim of current study was to determine in postmortem human brain samples the 
regulation of the HTR2A expression on the mRNA and protein level through different stages 
of development and aging in six brain regions. Furthermore, we assessed the effect of the 
HTR2A rs6311 polymorphism on HTR2A expression levels. 
 
Materials and Methods 
Subjects 
Human postmortem brain samples were obtained from the Department of 
Neuropathology, Institute of Pathology, University of Würzburg, Germany (member of the 
BrainNet Europe-BNEII) and the London Neurodegenerative Diseases Brain Bank, United 
Kingdom. For all analyzed samples written consent for tissue donation has been given either 
by the individuals or the next of kin. The study was approved by the Cantonal Ethic 
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Commission of Zürich (Ref. Nr. EK: KEK-ZH-Nr. 2013-0177). Samples were obtained from 
55 individuals with age ranging from 16 weeks of gestation to 91 years (yr) of age. Only 
samples from individuals with no clinical or neuropathological evidence of neuropsychiatric 
disorders were included in the current study. Tissue from six brain regions was collected: 
frontal cortex (n=54), striatum (n=52), amygdala (n=47), thalamus (n=52), brain stem (n=49) 
and cerebellum (n=47). Samples were divided in 5 age groups: fetal, 0-2 yr, 21-40 yr, 41-60 
yr, and over 60 yr. Demographic characteristics for the 5 age groups are presented in Table 1. 
The causes of death for the subjects included in the study are presented in Supplementary 
Table S1.  
 
DNA, RNA and protein isolation 
Frozen tissue samples with weight range of 27 – 34 mg were processed for 
simultaneous DNA, RNA and protein isolation with the Qiagen AllPrep DNA/RNA/Protein 
Mini Kit (Qiagen, Hombrechtikon, Switzerland). Briefly, tissue samples were disrupted and 
homogenized in the provided buffer using the TissueLyser II (Qiagen). DNA was eluted after 
applying the lysate on an AllPrep DNA spin column. After adding ethanol, the sample was 
applied to an RNeasy spin column, where total RNA was eluted. Proteins in the sample were 
precipitated and pelleted by centrifugation. Since the provided buffer in the kit for dissolving 
proteins interferes with protein determination and did not allow complete dissolving of 
proteins, protein eluates were acetone precipitated and redissolved in urea buffer (7M urea, 
2M thiourea, 2% CHAPS and trace bromophenol, pH 8). 
 
Quantitative Real Time RT-PCR (qRT-PCR) Analysis 
RNA concentrations, A260/A280 and A260/A230 ratios were measured with the 
NanoVue Plus spectrophotometer (GE Healthcare). In a subset of samples RNA integrity 
was also analyzed with the Experion automated electrophoresis system (Bio-Rad, 
Reinach, Switzerland). 500 ng mRNA were reverse transcribed using the iScript cDNA 
Synthesis kit (Bio-Rad). qRT-PCR analysis was carried out using QuantiFast SYBR Green 
PCR kit (Qiagen) and primers specific for the human HTR2A gene (primer assay number 
QT00054306, Qiagen), and the following reference genes: β-actin (ACTB) (QT01680476), 
aminolevulinate synthetase (ALAS1) (QT00073122), ribosomal protein L13a (RPL13A) 
(QT00089915), alanyl-tRNA synthetase (AARS) (QT00054747), glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) (QT01192646), peptidyl prolyl isomerase A (PPIA) (QT00866137), 
ribosomal RNA (R18S) (QT00019936), and X-prolyl aminopeptidase 1 (XPNPEP1) 
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(QT00051471). Eight reference genes were selected for testing in the current study based 
on previous investigations on reference genes stability in human postmortem tissue [13, 
14]. Mean PCR efficiencies were in the range between 78 and 83 % for all the amplicons 
studied, and were calculated using the “LinRegPCR program” [15]. Quantification of 
normalized HTR2A mRNA levels was carried out using the “Biogazelle qBASE plus” 
software (Biogazelle). The “Biogazelle qBASE plus” program utilizes gene specific PCR 
efficiency correction, selects automatically reference genes, by taking into account their 
stability for normalization and carries out multiple reference gene normalization [16]. 
 
Genotyping for the rs6311 HTR2A polymorphism 
DNA isolated from frontal cortex and in one case cerebellum was used for genotyping. 
DNA concentrations and A260/A280 and A260/A230 ratios were determined on the NanoVue 
Plus spectrophotometer. For genotyping the rs6311 HTR2A polymorphism, DNA, SNP 
genotyping assay for rs6311 (assay number C_8695278_10, Life Technologies) and TaqMan 
universal PCR master mix (Life Technologies) were combined in the 384-well plate. They 
were analyzed with the TaqMan SNP Genotyping Assay PCR standard protocol of Applied 
Biosystems, 07/2010 on a C1000 CFX384 thermal cycler (Bio-Rad). Analysis of the 
genotypes was performed with allelic discrimination program on the iCycler software (Bio-
Rad). Bio-Rad CFX Manager software 2.1 was used for the analysis of the results. The allele 
frequencies did not deviate from the Hardy-Weinberg equilibrium, assessed with the 
Had2Know Hardy-Weinberg equilibrium calculator for two alleles 
(http://www.had2know.com/academics/hardy-weinberg-equilibrium-calculator-2-
alleles.html). 
 
Western blot analysis 
Determination of protein levels was carried out with the Bradford assay (Sigma-
Aldrich) [17]. Protein lysates were mixed with loading buffer and reducing agent (both from 
Life Technologies) and heated at 46 °C for 10 min. Lysates were then loaded on NuPage 4-
12% Bis-Tris gels (Life Technologies) and after gel electrophoresis transferred onto 
nitrocellulose membranes with the iBlot western blotting system (Life Technologies). 
Membranes were blocked with 5% non-fat milk in phosphate buffered saline with 0.1% 
Tween 20 (PBST), and incubated with primary antibody against HTR2A (A-4, diluted 1:500 
to 1:1000 in 5% nonfat dry milk-PBST for different brain regions, Santa Cruz Biotechnology) 
or β-actin (diluted 1:10000 in 5% nonfat dry milk-PBST, Santa Cruz Biotechnology) 
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overnight at 4 °C. Membranes were washed three times with PBST, and incubated with anti-
mouse secondary HRP-conjugated antibody (diluted 1:2000 in 5% nonfat dry milk-PBST, 
Santa Cruz Biotechnology) for one hour at room temperature. Protein visualization was 
carried out with ECL Advance (GE Healthcare, Glattbrugg, Switzerland) on ChemiDoc 
XRS+ (Bio-Rad). Results were quantified with ImageJ 1.47 software (NIH). 
 
Statistical Analysis 
Statistical analysis was carried out using SPSS 21 from IBM. Normality of the 
distribution of mRNA and protein data was assessed with the Kolmogorov-Smirnov test with 
Liliefors significance correction. Both normal and no normal distribution for HTR2A 
mRNA and protein levels was observed between different brain regions. To ascertain 
consistency between statistical evaluations throughout the study, differences in HTR2A 
mRNA levels, protein levels and mRNA/protein ratios between the different age groups 
were analyzed by the nonparametric Kruskal-Wallis test, followed by Mann-Whitney 
test pair-wise comparisons with p-value threshold adjusted based on the number of 
comparisons (p<0.005). The only exception was the HTR2A mRNA/protein ratio in the 
thalamus, where correlation of the ratio with the postmortem interval (PMI) was 
detected, and analysis of covariance (ANCOVA) with PMI as covariate after logarithmic 
transformation of the data was used for assessment. Correlations between age and HTR2A 
mRNA and protein levels were assessed using Spearman’s rank correlation. Correlations 
between age and HTR2A mRNA and protein levels for statistical significance determination 
were carried for all samples in a certain brain region as one group. Correlations are presented 
graphically (Figures 1-6) with best fit lines for the fetal and 0-2 yr samples as one group and 
the 21-40 yr, 41-60 yr and over 60 yr samples as a second group for easier visualization of the 
results on the age scale. To study the effect of rs6311 genotype (AA, AG and GG) on HTR2A 
mRNA and protein expression, ANCOVA with age as a covariate was used (in brain regions 
where HTR2A mRNA and protein levels were not normally distributed, logarithmic 
transformation of the data was carried out for the ANCOVA test, which resulted in lognormal 
distribution).  
 
Results 
In our data set gender had no significant effect on HTR2A mRNA or protein levels in 
any of the brain regions studied (Mann-Whitney test, p > 0.05) (data not shown). The length 
of PMI did not differ significantly between the different age groups – Kruskal-Wallis 
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test λ2(4, N=55)=5.32, p=0.256. There was no significant correlation between the PMI and 
HTR2A mRNA levels, protein levels and mRNA/protein ratios in the studied brain regions 
(Spearman’s correlation, p>0.05), with the exception of the HTR2A mRNA/protein ratio 
in thalamus (Spearman’s correlation, p<0.05) (data not shown).  
 
Regulation of HTR2A mRNA and protein expression in frontal cortex with age 
HTR2A mRNA levels in frontal cortex were lowest in the fetal period and higher in 
the 0-2 yr, 21-40 yr, 41-60 yr, and over 60 yr groups - Kruskal-Wallis test λ2(4, 
N=50)=22.518, p < 0.001. Pair-wise comparisons, using Mann-Whitney test were significant 
(p<0.005) for - fetal vs. 0-2 yr; fetal vs. 21-40 yr; fetal vs. 41-60 yr; and fetal vs. over 60 yr 
groups (Figure 1A). There was statistically significant positive correlation between age and 
HTR2A mRNA levels in frontal cortex - rs(50) = 0.326, p = 0.021 (Figure 1B). 
HTR2A protein levels in frontal cortex were lowest in the fetal period and increased 
throughout the older age groups with highest levels in the above 60 yr age group - Kruskal-
Wallis test λ2(4, N=49)=28.065, p < 0.001. Pair-wise comparisons with Mann-Whitney test 
were significant (p<0.005) for - fetal vs. 21-40 yr; fetal vs. 41-60 yr; fetal vs. over 60 yr; and 
0-2 yr vs. over 60 yr groups (Figure 1C). There was statistically significant positive 
correlation between age and HTR2A protein levels in frontal cortex - rs(49) = 0.737, p<0.001 
(Figure 1D). 
 
Regulation of HTR2A mRNA and protein expression in striatum with age 
Differences in HTR2A mRNA levels in striatum did not reach significance between the 
different age groups - Kruskal-Wallis test λ2(4, N=47)=8.775, p=0.067 (Figure 2A). However, 
there was a statistically significant negative correlation between age and HTR2A mRNA 
levels in striatum: rs(47) = -0.466, p = 0.001 (Figure 2B).  
HTR2A protein levels in striatum also did not show significant differences between 
the age groups - Kruskal-Wallis test λ2(4, N=37)=5.963, p=0.202 (Figure 2C). There was also 
no significant correlation between age and HTR2A protein levels in the striatum: rs(37) = 
0.299, p = 0.072 (Figure 2D). 
 
Regulation of HTR2A mRNA and protein expression in amygdala with age 
In amygdala HTR2A mRNA levels showed an increase in the older age groups - 
Kruskal-Wallis test λ2(4, N=46)=10.421, p=0.034. Pair-wise comparisons, using Mann-
Whitney test were significant (p<0.005) for - fetal vs. 41-60 yr; and fetal vs. over 60 yr 
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groups (Figure 3A). There was no significant correlation between age and HTR2A mRNA 
levels in the amygdala: rs(46) = 0.271, p = 0.068 (Figure 3B).  
HTR2A protein levels in amygdala were lowest in the fetal group and higher in the 
older age groups - Kruskal-Wallis test λ2(4, N=40)=15.868, p=0.003. Pair-wise 
comparisons, using Mann-Whitney test were significant (p<0.005) for - fetal vs. 0-2 yr; 
fetal vs. 21-40 yr; fetal vs. 41-60 yr; and fetal vs. over 60 yr groups (Figure 3C). There was a 
positive correlation between age and HTR2A protein levels in amygdala: rs(40) = 0.557, 
p<0.01 (Figure 3D). 
 
Regulation of HTR2A mRNA and protein expression in thalamus with age 
In thalamus there were no significant differences between the different age groups in 
HTR2A mRNA levels - Kruskal-Wallis test λ2(4, N=46)=1.24, p=0.871 (Figure 4A). There 
was also no statistically significant correlation between age and the HTR2A mRNA levels in 
the thalamus (rs(46) = -0.014, p >0.05) (Figure 4B). 
HTR2A protein levels in the thalamus were lowest in the fetal period, and increased in 
the 21-40 yr, 41-60 yr and over 60 yr age groups - Kruskal-Wallis test λ2(4, N=44)=26.974, 
p<0.001. Pair-wise comparisons, using Mann-Whitney test were significant (p<0.005) for 
- fetal vs. 0-2 yr; fetal vs. 21-40 yr; fetal vs. 41-60 yr; fetal vs. over 60 yr; and 0-2 yr vs. 
over 60 yr groups (Figure 4C). There was a positive correlation between age and HTR2A 
protein levels in the thalamus. The correlation between age and HTR2A protein levels was 
rs(44) = 0.738, p < 0.01 (Figure 4D). 
 
Regulation of HTR2A mRNA and protein expression in brain stem with age 
HTR2A mRNA levels in the brain stem were higher in the fetal group compared to the 
over 60 yr group - Kruskal-Wallis test λ2(4, N=42)=12.872, p=0.012. Pair-wise Mann-
Whitney comparisons were significant for fetal vs. over 60 yr p=0.002 (Figure 5A). There 
was a negative correlation between age and HTR2A mRNA levels in the brain stem: rs(42) = -
0.569, p < 0.01 (Figure 5B).  
HTR2A protein levels in the brain stem were lowest in the fetal period and increased 
in the older age groups - Kruskal-Wallis test λ2(4, N=42)=13.249, p=0.01. Pair-wise Mann-
Whitney comparisons were significant for: fetal vs. 0-2 yr; fetal vs. 21-40 yr; fetal vs. 41-
60 yr; and fetal vs. over 60 yr (Figure 5C). There was a positive correlation between age and 
HTR2A protein levels in the brain stem: rs(42) = 0.426, p < 0.01 (Figure 5D). 
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Regulation of HTR2A mRNA and protein expression in cerebellum with age 
HTR2A mRNA levels in the cerebellum decreased with age with highest levels in the 
fetal period and 0-2 yr groups and lowest in the 41-60 yr and over 60 yr age groups - Kruskal-
Wallis test λ2(4, N=43)=19.056, p=0.001; pair-wise Mann-Whitney comparisons were 
significant (p<0.005) for fetal vs. 41-60 yr; fetal vs. over 60 yr; 0-2yr vs. 41-60 yr; and 0-2 yr 
vs over 60 yr groups (Figure 6A). There was a negative correlation between age and HTR2A 
mRNA levels in cerebellum: rs(43) = -0.53, p < 0.01 (Figure 6B).  
HTR2A protein levels in the cerebellum increased with age with lowest levels in the 
fetal and 0-2 yr groups and highest in the 41-60 yr and over 60 yr groups - Kruskal-Wallis test 
λ2(4, N=40)=22.748, p=0.001; pair-wise Mann-Whitney comparisons were significant 
(p<0.005) for: fetal vs. 41-60 yr; fetal vs. over 60 yr; 0-2 yr vs. 41-60 yr; and 0-2 yr vs over 
60 yr groups (Figure 6C). There was a positive correlation between age and HTR2A protein 
levels in cerebellum: rs(40) = 0.54, p < 0.01 (Figure 6D). 
 
Alterations in HTR2A mRNA/protein ratios in different brain regions with age 
The HTR2A mRNA/protein ratios in the different age groups were studied. 
HTR2A mRNA/protein ratios were negatively correlated with age in all brain regions 
(Supplementary Table S2) - rs = -0.629 for frontal cortex, -0.491 for striatum, -0.33 for 
amygdala, -0.606 for thalamus, -0.607 for brain stem, -0.588 for cerebellum, p<0.05 for 
all regions. There was a consistent trend for highest HTR2A mRNA/protein ratios in the 
fetal group and lower HTR2A mRNA/protein ratios in the older age groups throughout 
all brain regions studied, even though its extent showed variation between the brain 
regions (Supplementary Figure S1). The differences were significant in frontal cortex 
(λ2(4, N=46)=19.527, p=0.001), brain stem (λ2(4, N=36)=14.465, p=0.006), and cerebellum 
(λ2(4, N=38)=24.906, p<0.001) assessed with Kruskal-Wallis test. They were also 
significant in thalamus assessed with ANCOVA with PMI as covariate, followed by LSD 
post-hoc test (p<0.05). The differences did not reach significance for striatum (λ2(4, 
N=33)=7.446, p=0.114) and amygdala (λ2(4, N=40)=6.393, p=0.172) assessed with 
Kruskal-Wallis test. 
 
rs6311 HTR2A polymorphism and HTR2A mRNA and protein expression 
No significant differences in HTR2A mRNA or protein levels were detected among the 
rs6311 HTR2A genotypes (AA, AG, GG) in any of the brain regions studied (ANCOVA with 
age as covariate, p>0.05) (Figure 7A-L).  
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Discussion 
In the current study HTR2A mRNA and protein expression levels during different 
stages of development and aging and in six brain regions were analyzed using postmortem 
human brain samples from individuals with no clinical or neuropathological evidence of 
neuropsychiatric disorders. Our data showed regulation of HTR2A expression with age that 
was specific for each brain region studied. In particular, significant differences in HTR2A 
expression between different age groups were found in the frontal cortex (mRNA and protein 
levels), amygdala (mRNA and protein levels), thalamus (protein levels), brain stem (mRNA 
and protein levels), and cerebellum (mRNA and protein levels). Furthermore, the fetal period 
was identified as the age group, which differed most strongly in its HTR2A expression in 
comparison to all other age groups studied. 
 The HTR2A receptor has been implicated by postmortem, genetic and imaging studies 
in a number of psychiatric disorders [6]. Thus, changes in HTR2A expression levels in 
postmortem brain have been detected in schizophrenia [18-20]. In line with these findings, a 
recent meta-analysis confirmed a significant association of the rs6311 HTR2A polymorphism 
with schizophrenia [21]. Previous postmortem studies have observed changed HTR2A levels 
in brains from individuals with major depression (in prefrontal cortex and hippocampus) 
[4, 22], and suicide victims (in frontopolar and prefrontal cortex, hippocampus and 
amygdala) [23-26].  
Animal studies have suggested that windows of vulnerability to environmental 
influences may exist in neuronal development, disruptions in signaling during which may be 
particularly damaging and increasing the vulnerability to psychiatric disorders [27]. In order 
to understand changes occurring in psychiatric disorders, it is important to analyze the normal 
developmental pattern of signaling molecules in the brain [28]. In our study HTR2A 
expression levels showed greatest differences compared to other age groups in the fetal group, 
underscoring this developmental period as particularly important for the plastic regulation of 
expression. Our data are in agreement with a recent transcriptome and genome study of 
prefrontal human cortex, which identified fetal development as the period during which 
overall gene expression changes occur much faster compared to other age periods [29]. 
Interestingly, in the oldest age group in the current study – over 60 yr, HTR2A protein 
levels were generally relatively higher compared to the mRNA levels for the corresponding 
brain region. This effect could be specific to the HTR2A receptor or a more widely occurring 
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phenomenon. It could be related to alterations in post-transcriptional modifications with age – 
for example related to the ubiquitin-proteasome system or microRNA regulation and warrants 
further investigation [30, 31]. 
Our study involved six brain regions – frontal cortex, striatum, amygdala, thalamus, 
brain stem and cerebellum. We found that regulation of HTR2A expression with age was 
specific for each brain region, emphasizing the importance of analyzing data from 
postmortem studies in the context of the brain region studied. These regional specificities in 
regulation are important in light of the potential for interaction with different neurotransmitter 
systems and the function of the HTR2A receptor in each brain area. While the process of 
brain development is very complex and encompasses a long period of time, some 
regional specificities can be noted. They can be related to the processes of neuronal 
plasticity and activity, as well as to synaptic density. For example, the processes of 
synaptogenesis and synapse elimination, which are an essential part of brain 
development, apparently occur with varying time courses in different regions of the 
human cerebral cortex [32, 33]. 
The levels of serotonin and its metabolites have been studied in postmortem 
human brain. In putamen, increase in serotonin levels and decrease in the levels of its 
metabolite 5-hydroxyidoleacetic acid have been observed with age, starting from the 
second decade of life [34]. The dependence of monoamine oxidase A activity, which is 
particularly important for serotonin metabolism, on age in frontal cortex has also been 
investigated. A fast decrease in monoamine oxidase A activity in postmortem frontal 
cortex in the first two years after birth and stable levels afterwards has been observed 
[35]. A direct correlation between serotonin levels alterations with age from previous 
studies and our results on HTR2A levels is difficult due to the diverse brain regions and 
age ranges studied. 
The rs6311 HTR2A polymorphism has been associated with potential changes in 
HTR2A expression levels [36], but these findings have not been consistently replicated [37-
39]. A recent study also suggested that the rs6311 polymorphism decreases the usage of an 
upstream transcription start site, which encodes a longer 5’-untranslated region with higher 
translation efficiency [7]. We assessed the effect of the rs6311 polymorphism on the HTR2A 
mRNA and protein levels in the different brain regions studied and did not find any 
statistically significant differences between the genotypes. The observed lack of the rs6311 
HTR2A polymorphism on HTR2A expression levels may be related to the relatively small 
sample size in our study. In addition, HTR2A mRNA and protein expression was correlated 
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with age in a number of brain regions in our study. An investigation including a larger number 
of samples closely matched by age is warranted to conclusively assess the effect of the rs6311 
HTR2A polymorphism of HTR2A expression levels in postmortem brain samples. 
In conclusion, our results showed regulation of HTR2A mRNA and protein levels in 
postmortem brain with age, which was brain region-specific. The data of the current study 
will contribute to better understanding of the regulation of HTR2A brain expression in 
development and aging. 
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Figures legends: 
 
Figure 1. Developmental regulation of HTR2A mRNA and protein expression in frontal 
cortex. A. HTR2A mRNA levels in frontal cortex across the different age groups presented as 
mean±SEM. HTR2A mRNA levels change significantly through development assessed with 
Kruskal-Wallis test, * presents statistical significance between groups assessed with Mann-
Whitney tests (p<0.005). B. Correlation between age and HTR2A mRNA levels in frontal 
cortex - rs(50) = 0.326, p = 0.021, linear fit lines and 95% confidence interval (CI) included.  
C. HTR2A protein levels in frontal cortex across the different age groups presented as 
mean±SEM. HTR2A protein levels change significantly through development assessed with 
Kruskal-Wallis test, * presents statistical significance between groups assessed with Mann-
Whitney tests (p<0.005). D. Correlation between age and HTR2A protein levels in frontal 
cortex - rs(49) = 0.737, p < 0.001, linear fit lines and 95% CI included. 
 
Figure 2. Developmental regulation of HTR2A mRNA and protein levels in striatum. A. 
HTR2A mRNA levels in striatum across the different age groups presented as mean±SEM. B. 
Correlation between age and HTR2A mRNA levels in striatum - rs(47) = -0.466, p = 0.001, 
linear fit lines and 95% CI included. C. HTR2A protein levels in striatum across the different 
age groups presented as mean±SEM. D. Correlation between age and HTR2A protein levels 
in striatum, linear fit lines and 95% CI included. 
 
Figure 3. Developmental regulation of HTR2A mRNA and protein levels in amygdala. A. 
HTR2A mRNA levels in amygdala across the different age groups presented as mean±SEM. 
HTR2A mRNA levels change significantly through development assessed with Kruskal-
Wallis test, * presents statistical significance between groups assessed with Mann-
Whitney tests (p<0.005). B. Correlation between age and HTR2A mRNA levels in amygdala, 
linear fit lines and 95% included. C. HTR2A protein levels in amygdala across the different 
age groups presented as mean±SEM. HTR2A protein levels change significantly through 
development assessed with Kruskal-Wallis test, * presents statistical significance between 
groups assessed with Mann-Whitney tests (p<0.005). D. Correlation between age and 
HTR2A protein levels in amygdala - rs(40) = 0.557, p<0.01, linear fit lines and 95% CI 
included.  
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Figure 4. Developmental regulation of HTR2A mRNA and protein levels in thalamus. A. 
HTR2A mRNA levels in thalamus across the different age groups presented as mean±SEM. B. 
Correlation between age and HTR2A mRNA levels in thalamus, linear fit lines and 95% CI 
included. C. HTR2A protein levels in thalamus across the different age groups presented as 
mean±SEM. HTR2A protein levels change significantly through development assessed with 
Kruskal-Wallis test, * presents statistical significance between groups assessed with 
Mann-Whitney tests (p<0.005). D. Correlation between age and HTR2A protein levels in 
thalamus - rs(44) = 0.738, p < 0.01, linear fit lines and 95% CI included. 
 
Figure 5. Developmental regulation of HTR2A mRNA and protein levels in brain stem. A. 
HTR2A mRNA levels in brain stem across the different age groups presented as mean±SEM. 
HTR2A mRNA levels change significantly through development assessed with Kruskal-
Wallis test, * presents statistical significance between groups assessed with Mann-Whitney 
tests (p<0.005). B. Correlation between age and HTR2A mRNA levels in brain stem - rs(42) = 
-0.569, p < 0.01, linear fit lines and 95% CI included. C. HTR2A protein levels in brain stem 
across the different age groups presented as mean±SEM. HTR2A protein levels change 
significantly through development assessed with Kruskal-Wallis test, * presents statistical 
significance between groups assessed with Mann-Whitney tests (p<0.005). D. Correlation 
between age and HTR2A protein levels in brain stem - rs(42) = 0.426, p < 0.01, linear fit lines 
and 95% CI included. 
 
Figure 6. Developmental regulation of HTR2A mRNA and protein levels in cerebellum. A. 
HTR2A mRNA levels in cerebellum across the different age groups presented as mean±SEM. 
HTR2A mRNA levels change significantly through development assessed with Kruskal-
Wallis test, * presents statistical significance between groups assessed with Mann-Whitney 
tests (p<0.005). B. Correlation between age and HTR2A mRNA levels in cerebellum rs(43) = -
0.53, p < 0.01, linear fit lines and 95% CI included. C. HTR2A protein levels in cerebellum 
across the different age groups presented as mean±SEM. HTR2A protein levels change 
significantly through development assessed with Kruskal-Wallis test, * presents statistical 
significance between groups assessed with Mann-Whitney tests (p<0.005). D. Correlation 
between age and HTR2A protein levels in cerebellum - rs(40) = 0.54, p < 0.01, linear fit lines 
and 95% CI included. 
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Figure 7. HTR2A mRNA and protein levels in different brain regions of subjects grouped 
depending on their rs6311 HTR2A genotype (AA, AG, GG). HTR2A mRNA levels in frontal 
cortex (A), striatum (B), amygdala (C), thalamus (D), brain stem (E) and cerebellum (F) 
between different rs6311 HTR2A genotypes. HTR2A protein levels in frontal cortex (G), 
striatum (H), amygdala (I), thalamus (J), brain stem (K) and cerebellum (L) between 
different rs6311 HTR2A genotypes. Both HTR2A mRNA and protein levels are presented as 
mean±SEM. 
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Table 1. Demographic characteristics of the subjects included in the study by age group. 
Age groups Gender Average age ± SD PMI ± SD (h) 
fetal 7 F / 4 M 21.3  ± 6.86 g. w. 36.9 ± 19.9 
0-2 yr 5 F / 6 M 0.62 ± 0.6 yr 25.5 ± 7.7 
21-40 yr 2 F / 3 M 32 ± 6 yr 25.8 ± 18.3 
41- 60 yr 5 F / 6 M 50.9 ± 5.1 yr 26.9 ± 12.5 
over 60 yr 6 F / 11 M 73.6 ± 8.6 yr 25.9 ± 10.2  
Abbreviations: F=female, M=male, yr=years, g. w.=gestational weeks, PMI=postmortem 
interval, h=hours  
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